Sign In
Share

Engerix-B (Engerix-B)

All Clinical Trials

Common TitleLong-Term Immunity with Engerix-B Industry
Official Title Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated 20 to 30 Years Ago With Engerix-B
ClinicalTrials.gov NCT02901951
Treatments
Engerix-B

Engerix-B

Tradename:Engerix-BClass:Vaccines (HBV)
Funding
IndustryGlaxoSmithKline
References
  • Van Den Ende C, Marano C, Van Ahee A, Bunge EM, De Moerlooze L. The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev Vaccines. 2017;16:811-32.
    [PubMed Abstract]
Common TitleEngerix-B in Type 2. Diabetes Mellitus Industry
Official Title An Open-label Study to Assess the Immunogenicity and Safety of GSK Biologicals' Hepatitis B Vaccine, Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
ClinicalTrials.gov NCT01627340
Treatments
Engerix-B

Engerix-B

Tradename:Engerix-BClass:Vaccines (HBV)
Funding
IndustryGlaxoSmithKline
References
  • Van Der Meeren O, Peterson JT, Dionne M, et al. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. Hum Vaccin Immunother. 2016;12:2197-2203.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.